Editorial: How Much Do PPIs Contribute to C. difficile Infections?

Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis

(2012) Sailajah Janarthanan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Recent Safety Concerns With Proton Pump Inhibitors

(2012) Joan Chen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The risks of PPI therapy

(2012) Paul Moayyedi et al.   Nature Reviews Gastroenterology & Hepatology

Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection

(2010) Michael D. Howell   ARCHIVES OF INTERNAL MEDICINE

The Changing Epidemiology of Clostridium difficile Infections

(2010) J. Freeman et al.   CLINICAL MICROBIOLOGY REVIEWS

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

(2009) Mark Miller et al.   CLINICAL INFECTIOUS DISEASES

Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical Inpatients

(2008) E. R. Dubberke et al.   CLINICAL INFECTIOUS DISEASES

Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole

(2008) Lennart Estborn et al.   DRUG SAFETY

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal